Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model
Highlights: • Sorafenib decreased blood flow in the vasculature by narrowing the vascular diameter. • Histidine maintained the blood flow by dilating the vascular diameter of the existing vessel. • Histidine was useful for managing the sorafenib related vascular damage. • No positive effect of histidine was seen on the tumor progression or on the novel regenerating vessels. • A fli::GFP transgenic medaka is useful for analyzing the vascular changes under the administration of these chemicals. Sorafenib (SFN) is an anti-angiogenic chemotherapeutic that prolongs survival of patients with hepatocellular carcinoma (HCC); its side effects, including vascular damages such as hand-foot syndrome (HFS), are a major cause of therapy discontinuation. We previously reported that maintenance of peripheral blood flow by intake of dried bonito broth (DBB) significantly prevented HFS and prolonged the administration period. The amino acids contained in DBB probably contribute to its effects, but the mechanism has not been clarified. We hypothesized that histidine, the largest component among the amino acids contained in DBB, has effects on SFN-induced vascular damage, and evaluated this possibility using a novel medaka fish model.